185 related articles for article (PubMed ID: 23660814)
1. Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide.
Jalkute CB; Barage SH; Dhanavade MJ; Sonawane KD
Protein J; 2013 Jun; 32(5):356-64. PubMed ID: 23660814
[TBL] [Abstract][Full Text] [Related]
2. Exploring mode of phosphoramidon and Aβ peptide binding to hECE-1 by molecular dynamics and docking studies.
Barage SH; Sonawane KD
Protein Pept Lett; 2014; 21(2):140-52. PubMed ID: 24000822
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor and substrate binding by angiotensin-converting enzyme: quantum mechanical/molecular mechanical molecular dynamics studies.
Wang X; Wu S; Xu D; Xie D; Guo H
J Chem Inf Model; 2011 May; 51(5):1074-82. PubMed ID: 21520937
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a possible role of Stigmatella aurantiaca ACE in Aβ peptide degradation: a molecular modeling approach.
Jalkute CB; Sonawane KD
J Mol Microbiol Biotechnol; 2015; 25(1):26-36. PubMed ID: 25677850
[TBL] [Abstract][Full Text] [Related]
6. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.
Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED
FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
Natesh R; Schwager SL; Sturrock ED; Acharya KR
Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
9. Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors.
Chamata Y; Watson KA; Jauregi P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013233
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from Xanthomonas campestris in degradation of Aβ peptide.
Dhanavade MJ; Jalkute CB; Barage SH; Sonawane KD
Comput Biol Med; 2013 Dec; 43(12):2063-70. PubMed ID: 24290922
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of a novel angiotensin-converting enzyme-inhibitory tripeptide from enzymatic hydrolysis of soft-shelled turtle (Pelodiscus sinensis) egg white: in vitro, in vivo, and in silico study.
Rawendra RD; Aisha ; Chen SH; Chang CI; Shih WL; Huang TC; Liao MH; Hsu JL
J Agric Food Chem; 2014 Dec; 62(50):12178-85. PubMed ID: 25402658
[TBL] [Abstract][Full Text] [Related]
12. Comparison of an angiotensin-I-converting enzyme inhibitory peptide from tilapia (Oreochromis niloticus) with captopril: inhibition kinetics, in vivo effect, simulated gastrointestinal digestion and a molecular docking study.
Chen J; Ryu B; Zhang Y; Liang P; Li C; Zhou C; Yang P; Hong P; Qian ZJ
J Sci Food Agric; 2020 Jan; 100(1):315-324. PubMed ID: 31525262
[TBL] [Abstract][Full Text] [Related]
13. Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril.
Watermeyer JM; Kröger WL; O'Neill HG; Sewell BT; Sturrock ED
Biochem J; 2010 Apr; 428(1):67-74. PubMed ID: 20233165
[TBL] [Abstract][Full Text] [Related]
14. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA
Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE.
Fernandez JH; Hayashi MA; Camargo AC; Neshich G
Biochem Biophys Res Commun; 2003 Aug; 308(2):219-26. PubMed ID: 12901857
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I-converting enzyme inhibitory activity.
Vukic VR; Vukic DV; Milanovic SD; Ilicic MD; Kanuric KG; Johnson MS
Nutr Res; 2017 Oct; 46():22-30. PubMed ID: 29173648
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril.
Kim HM; Shin DR; Yoo OJ; Lee H; Lee JO
FEBS Lett; 2003 Mar; 538(1-3):65-70. PubMed ID: 12633854
[TBL] [Abstract][Full Text] [Related]
19. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
20. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship.
Jimsheena VK; Gowda LR
Peptides; 2010 Jun; 31(6):1165-76. PubMed ID: 20214946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
